Rituximab Concentration Varies in Patients With Different Lymphoma Subtypes and Correlates With Clinical Outcome

Individual variations in concentrations of rituximab in different B cell non-Hodgkin’s lymphoma subtypes and their relevance to efficacy were still unclear. From 2016 to 2021, a prospective clinical trial was conducted, and 510 samples with 6 uncommon subtypes of B-cell lymphoma were enrolled to exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shu, Wang, Zhao, Chen, Rongxin, Wang, Xueding, Fang, Xiaojie, Chen, Zhuojia, Guan, Shaoxing, Liu, Tao, Lin, Tongyu, Huang, Min, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832337/
https://www.ncbi.nlm.nih.gov/pubmed/35153779
http://dx.doi.org/10.3389/fphar.2022.788824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832337/
https://www.ncbi.nlm.nih.gov/pubmed/35153779
http://dx.doi.org/10.3389/fphar.2022.788824

Ejemplares similares